Dune Medical Devices Ltd. - Locations And Subsidiaries
Dune Medical Devices Ltd., Recent Developments
Jun 21, 2016: First Patients Enrolled in United Kingdom's National Health Service Sponsored Clinical and Economic Study of Using MarginProbe During Breast Surgeries
May 10, 2016: Surgeons at Mercy Medical Center in Cedar Rapids preserve more breast tissue and reduce the need for additional surgery by 75% for breast cancer patients with targeted excision using MarginProbe
Apr 26, 2016: Latest Study Demonstrates 79% Reduction in Re-Excisions Without Additional Tissue Loss Using MarginProbe in Conjunction with Clear Margins Guidelines
Mar 23, 2016: MarginProbe Modification Receives FDA Pre-Market Approval
Feb 29, 2016: New study confirms MarginProbe demonstrates a 51% reduction in re-excision procedures
Feb 08, 2016: Dune Medical Devices' New U.S. President to Lead Continued Expansion
May 20, 2015: Significant Decreases in Re-Excision Rates Reported in Two Studies Using MarginProbe Presented at The American Society of Breast Surgeons Annual Meeting
Mar 04, 2015: New Study Shows Breast Re-excision Rates Significantly Reduced in 100 Consecutive Cases
Jan 05, 2015: Dune Medical Devices Announces FDA Approval of Updated Version of MarginProbe with Feature Enhancements, Further Improving User-Friendly Experience for Surgeons
Nov 07, 2014: Study Using MarginProbe Presented at American Society of Clinical Oncology 2014 Breast Cancer Symposium
List of Tables
Dune Medical Devices Ltd. Pipeline Products and Clinical Trials Overview
Dune Medical Devices Ltd. Pipeline Products by Equipment Type
Dune Medical Devices Ltd. Pipeline Products by Indication
Dune Medical Devices Ltd., Key Facts
Dune Medical Devices Ltd., Major Products and Services
Dune Medical Devices Ltd. Number of Pipeline Products by Development Stage
Dune Medical Devices Ltd. Pipeline Products Summary by Development Stage
Dune Medical Devices Ltd. (Dune Medical), a subsidiary of Dune Medical Devices Inc. is a medical device company that offers diagnostic products. The company develops and distributes tissue characterization devices including MarginProbe System that provides assessment of the tissue in breast cancer surgery. Its product offers cancer detection services for assessment in margin of excised tissue. Dune Medical’s product is used in the treatment of liver, kidney, sentinel nodes, esophagus, basal and squamous cell carcinomas, and other solid tumors. The company’s technology is based on the technology RF spectroscopy. It serves surgeons and radiologists. The company operates through offices in the US, and Israel. Dune Medical is headquartered in Caesarea, Israel.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Dune Medical Devices Ltd.
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio